Literature DB >> 28179599

The immune dysfunction in ankylosing spondylitis patients.

Zhongliang Duan1, Yuyan Gui, Cui Li, Jing Lin, Hans-Jürgen Gober, Juanxiu Qin, Dajin Li, Ling Wang.   

Abstract

Ankylosing spondylitis (AS) is a spinal arthritic disease that is often associated with human leukocyte antigen (HLA)-B27, while only part of HLA-B27 carriers become AS patients. T cells have been reported to play an important role in the pathology of AS. T-cell immunoglobulin and mucin-domain-containing molecule 3 (Tim-3) and programmed death-1 (PD-1) have been known to negatively regulate the immune response. In this study, we used flow cytometry to analyze the immunological differences of peripheral bloodfrom 21 patients with AS, 22 cases who didn't have AS but were found to be HLA-B27 positive (HLA-B27+ group), and 16 normal healthy individuals (Healthy group). The level of CD4+, CD8+ T cells,and Treg of each group was observed. The expression of Tim-3 and PD-1 and the production of IFN-γ, IL-6, TNF-α, IL-4, and IL-10 were examined as well. We found that the percentage of Treg in AS group was lower than that of healthy group. The expression of PD-1 on CD8+ T cells and Tim-3 on CD4+ T cells was lower in the AS group. AS group had lower IL-10 production by CD4+ T cells and higher IL-6 production by CD8+ T cells. The results of HLA-B27+ group were similar to that of the healthy group. These data suggested that patients with AS had an impairment in the ability to negatively regulate the immune response, which might be related to the etiology of AS. To further investigate the roles of Tim-3 and PD-1 on is a dysfunction of T cells in AS that is associated with PD-1 and Tim-3.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28179599     DOI: 10.5582/bst.2016.01171

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  11 in total

1.  Ankylosing spondylitis risk factors: a systematic literature review.

Authors:  Mark C Hwang; Lauren Ridley; John D Reveille
Journal:  Clin Rheumatol       Date:  2021-03-22       Impact factor: 3.650

2.  TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis.

Authors:  Mingcan Yang; Qing Lv; Qiujing Wei; Yutong Jiang; Jun Qi; Min Xiao; Linkai Fang; Ya Xie; Shuangyan Cao; Zhiming Lin; Yanli Zhang; Liudan Tu; Minjing Zhao; Yunfeng Pan; Ou Jin; Jieruo Gu
Journal:  Arthritis Res Ther       Date:  2020-06-19       Impact factor: 5.156

3.  Protein inhibitor of activated STAT3 reduces peripheral arthritis and gut inflammation and regulates the Th17/Treg cell imbalance via STAT3 signaling in a mouse model of spondyloarthritis.

Authors:  Hong-Ki Min; JeongWon Choi; Seon-Yeong Lee; Hyeon-Beom Seo; KyungAh Jung; Hyun Sik Na; Jun-Geol Ryu; Seung-Ki Kwok; Mi-La Cho; Sung-Hwan Park
Journal:  J Transl Med       Date:  2019-01-10       Impact factor: 5.531

Review 4.  The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis: A Meta-Analysis.

Authors:  Na-Lin Lai; Sheng-Xiao Zhang; Jia Wang; Jia-Qian Zhang; Cai-Hong Wang; Chong Gao; Xiao-Feng Li
Journal:  J Immunol Res       Date:  2019-10-23       Impact factor: 4.818

5.  Modulatory Impact of Adipose-Derived Mesenchymal Stem Cells of Ankylosing Spondylitis Patients on T Helper Cell Differentiation.

Authors:  Ewa Kuca-Warnawin; Iwona Janicka; Krzysztof Bonek; Ewa Kontny
Journal:  Cells       Date:  2021-01-30       Impact factor: 6.600

6.  Identification of immune related cells and crucial genes in the peripheral blood of ankylosing spondylitis by integrated bioinformatics analysis.

Authors:  Yang Zheng; Bingbing Cai; Conglin Ren; Haipeng Xu; Weibin Du; Yijiang Wu; Fu Lin; Helou Zhang; Renfu Quan
Journal:  PeerJ       Date:  2021-09-07       Impact factor: 2.984

Review 7.  The Potential Role of Genetics, Environmental Factors, and Gut Dysbiosis in the Aberrant Non-Coding RNA Expression to Mediate Inflammation and Osteoclastogenic/Osteogenic Differentiation in Ankylosing Spondylitis.

Authors:  Hsien-Tzung Liao; Chang-Youh Tsai; Chien-Chih Lai; Song-Chou Hsieh; Yi-Syuan Sun; Ko-Jen Li; Chieh-Yu Shen; Cheng-Han Wu; Cheng-Hsun Lu; Yu-Min Kuo; Tzu-Hao Li; Chung-Tei Chou; Chia-Li Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-20

8.  Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials.

Authors:  Liuting Zeng; Tiejun Yang; Kailin Yang; Ganpeng Yu; Jun Li; Wang Xiang; Hua Chen
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

Review 9.  Meta-Analysis of Changes in the Number and Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis.

Authors:  Ming Li; Xueping Zhou; Lingling Zhou; Zhichao Yu; Ling Fu; Pei Yang
Journal:  Biomed Res Int       Date:  2020-02-19       Impact factor: 3.411

10.  Imbalance of Peripheral Lymphocyte Subsets in Patients With Ankylosing Spondylitis: A Meta-Analysis.

Authors:  Dong Liu; Budian Liu; Churong Lin; Jieruo Gu
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.